430 related articles for article (PubMed ID: 12173027)
21. Analysis of the β-glucocerebrosidase gene in Turkish Gaucher disease patients: mutation profile and description of a novel mutant allele.
Karaca E; Kalkan S; Onay H; Aykut A; Coker M; Ozkinay F
J Pediatr Endocrinol Metab; 2012; 25(9-10):957-62. PubMed ID: 23426826
[TBL] [Abstract][Full Text] [Related]
22. DNA mutational analysis of type 1 and type 3 Gaucher patients: how well do mutations predict phenotype?
Sidransky E; Bottler A; Stubblefield B; Ginns EI
Hum Mutat; 1994; 3(1):25-8. PubMed ID: 8118463
[TBL] [Abstract][Full Text] [Related]
23. Gaucher disease: gene frequencies and genotype/phenotype correlations.
Grabowski GA
Genet Test; 1997; 1(1):5-12. PubMed ID: 10464619
[TBL] [Abstract][Full Text] [Related]
24. Clinical and molecular aspects of Gaucher disease in New Zealand.
Woodfield MJ; Woodfield DG; Winship IM
N Z Med J; 1997 Aug; 110(1050):316-9. PubMed ID: 9315031
[TBL] [Abstract][Full Text] [Related]
25. Identification of a 55-bp deletion in the glucocerebrosidase gene in Gaucher disease: phenotypic presentation and implications for mutation detection assays.
Mao R; O'Brien JF; Rao S; Schmitt E; Roa B; Feldman GL; Spence WC; Snow K
Mol Genet Metab; 2001 Mar; 72(3):248-53. PubMed ID: 11243731
[TBL] [Abstract][Full Text] [Related]
26. Phenotypic and genotypic heterogeneity in Gaucher disease type 1: a comparison between Brazil and the rest of the world.
Sobreira E; Pires RF; Cizmarik M; Grabowski GA
Mol Genet Metab; 2007 Jan; 90(1):81-6. PubMed ID: 16996765
[TBL] [Abstract][Full Text] [Related]
27. Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease.
Koprivica V; Stone DL; Park JK; Callahan M; Frisch A; Cohen IJ; Tayebi N; Sidransky E
Am J Hum Genet; 2000 Jun; 66(6):1777-86. PubMed ID: 10796875
[TBL] [Abstract][Full Text] [Related]
28. Molecular screening of Japanese patients with Gaucher disease: phenotypic variability in the same genotypes.
Kawame H; Maekawa K; Eto Y
Hum Mutat; 1993; 2(5):362-7. PubMed ID: 8257989
[TBL] [Abstract][Full Text] [Related]
29. [Gaucher disease: clinical, genetic and therapeutic aspects].
Germain DP
Pathol Biol (Paris); 2004 Jul; 52(6):343-50. PubMed ID: 15261378
[TBL] [Abstract][Full Text] [Related]
30. Genetic and clinical features of patients with Gaucher disease in Hungary.
Erdos M; Hodanova K; Taskó S; Palicz A; Stolnaja L; Dvorakova L; Hrebicek M; Maródi L
Blood Cells Mol Dis; 2007; 39(1):119-23. PubMed ID: 17395504
[TBL] [Abstract][Full Text] [Related]
31. New insights into the origin of the Gaucher disease-causing mutation N370S: extended haplotype analysis using the 5GC3.2, 5470 G/A, and ITG6.2 polymorphisms.
Rodríguez-Marí A; Díaz-Font A; Chabás A; Pastores GM; Grinberg D; Vilageliu L
Blood Cells Mol Dis; 2001; 27(5):950-9. PubMed ID: 11783960
[TBL] [Abstract][Full Text] [Related]
32. [Genetics of Gaucher's disease. Genotype-phenotype correlation].
Alfonso Palacín P; Pocoví M
Med Clin (Barc); 2011 Sep; 137 Suppl 1():17-22. PubMed ID: 22230121
[TBL] [Abstract][Full Text] [Related]
33. Divergent phenotypes in Gaucher disease implicate the role of modifiers.
Goker-Alpan O; Hruska KS; Orvisky E; Kishnani PS; Stubblefield BK; Schiffmann R; Sidransky E
J Med Genet; 2005 Jun; 42(6):e37. PubMed ID: 15937077
[TBL] [Abstract][Full Text] [Related]
34. Type I Gaucher's disease with homozygous R463C mutation without neurological involvement.
Bolaman Z; Kadikoylu G; Levi E; Barutca S; Temucin K
Haematologia (Budap); 2002; 32(4):487-93. PubMed ID: 12803123
[TBL] [Abstract][Full Text] [Related]
35. Gaucher disease: expression and characterization of mild and severe acid beta-glucosidase mutations in Portuguese type 1 patients.
Amaral O; Marcão A; Sá Miranda M; Desnick RJ; Grace ME
Eur J Hum Genet; 2000 Feb; 8(2):95-102. PubMed ID: 10757640
[TBL] [Abstract][Full Text] [Related]
36. A novel complex allele and two new point mutations in type 2 (acute neuronopathic) Gaucher disease.
Sinclair G; Choy FY; Humphries L
Blood Cells Mol Dis; 1998 Dec; 24(4):420-7. PubMed ID: 9851895
[TBL] [Abstract][Full Text] [Related]
37. Identification and characterization of a novel mutation c.1090G>T (G325W) and nine common mutant alleles leading to Gaucher disease in Spanish patients.
Torralba MA; Pérez-Calvo JI; Pastores GM; Cenarro A; Giraldo P; Pocoví M
Blood Cells Mol Dis; 2001; 27(2):489-95. PubMed ID: 11259172
[TBL] [Abstract][Full Text] [Related]
38. Mutation analysis of Gaucher disease patients from Argentina: high prevalence of the RecNciI mutation.
Cormand B; Harboe TL; Gort L; Campoy C; Blanco M; Chamoles N; Chabás A; Vilageliu L; Grinberg D
Am J Med Genet; 1998 Dec; 80(4):343-51. PubMed ID: 9856561
[TBL] [Abstract][Full Text] [Related]
39. Gaucher disease: complexity in a "simple" disorder.
Sidransky E
Mol Genet Metab; 2004; 83(1-2):6-15. PubMed ID: 15464415
[TBL] [Abstract][Full Text] [Related]
40. Functional analysis of 13 GBA mutant alleles identified in Gaucher disease patients: Pathogenic changes and "modifier" polymorphisms.
Montfort M; Chabás A; Vilageliu L; Grinberg D
Hum Mutat; 2004 Jun; 23(6):567-75. PubMed ID: 15146461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
